
|
|
12/14/2010
From ada.org
The U.S. Food and Drug Administration will convene a dental advisory panel Dec. 14-15 to discuss “whether FDA appropriately represented the strengths and weaknesses of the available clinical data” in issuing 2009 dental amalgam regulations. More
ADA News: No scientific reason to revisit amalgam, December 1, 2010